Search Results
Regulatory Issues & Psilocybin: Compass Pathways Ltd. - Ekaterina Malievskaia | 18th February 2019
The Incrementalist: Ekaterina Malievskaia, CMO & Co-Founder of COMPASS Pathways on Brain Health
27. Depression: The Psychedelic Cure | Katya Malievskaia & George Goldsmith
Making Psilocybin into a Medicine: A Multidisciplinary Approach - Panel Discussion With All Speakers
Florian Brand Talks of Innovation in Mental Healthcare to Tackle Depression, Anxiety and Addiction
Psychedelics: Therapeutic Mechanisms - Robin Carhart-Harris | 18th February 2019
Compass Pathways is Big Pharma - Bad Stock, Destructive, Corrosive, Anti-Legalization
Matthew Johnson - Therapeutic Effects of Psilocybin
Episode 9: Analyzing the atai Life Sciences IPO
